Tumor Ablation Market
Global Tumor Ablation Market Size, Share & Trends Analysis Report by Technology (Radio Frequency Ablation, Microwave Ablation, Cryoablation, and Percutaneous Ethanol Ablation) by Application (Liver Cancer, Lung Cancer, Breast Cancer, Prostate Cancer, and Others) by End-User (Hospitals, Surgical Clinics, and Research Institutions) Forecast 2022-2028
The global tumor ablation market is anticipated to grow at a considerable CAGR of 12.7% during the forecast period. Tumor ablation is the technology used for destroying the tumor which can be done by using imaging technology to place the needle into the tumor organ. The treatment can be done by using various technologies such as radiofrequency ablation, microwave ablation, cryoablation, and other such technologies. There are various cancers that can be treated by this technology such as lung cancer, liver tumor, prostate cancer, kidney tumor, and other tumors. The increasing incidence of cancer and the rising aging population is the major growth factors for tumor ablation market. Moreover, high efficacy and safety are majorly contributing to the growth.
The government and healthcare authorities are very much concern for using radio and microtechnology due to the side effects associated with it. Hence, it can hinder the growth of the tumor ablation market. However, the research and development in ablation technology for treating the primary breast cancer and adrenal neoplasm, as well as the improvement in imaging technology will fuel the growth of the market in future. Furthermore, the adoption of minimally invasive therapy will increase the usage of this technology and create a huge opportunity for this market.
Impact of COVID-19 Pandemic on Global Tumor Ablation Market
The COVID-19 pandemic has drastically affected the global tumor ablation market. In March-July 2020 in comparison with 2019, there was a substantial decrease in cancer screenings, biopsies, surgeries, office visits, and therapy with variation by cancer type and site of service. According to the American Society of Clinical Oncology report published in 2019, stated that, at the peak of the pandemic in April, screenings for breast, colon, prostate, and lung cancers were lower by 85%, 75%, 74%, and 56%, respectively, the tumor patients are at high risk and faced issues in accessing care. Patients with cancer have reported delays in receiving cancer care, including follow-up clinic appointments and cancer therapies, such as radiation, infusion therapies, and surgical tumor removal.
Segmental Outlook
The global tumor ablation market is segmented on the basis on technology, application, and end user. Based on technology, the market is sub-segmented into radio frequency ablation, microwave ablation, cryoablation, and percutaneous ethanol ablation. Based on application, the market is bifurcated into liver cancer, lung cancer, breast cancer, prostate cancer, and others. Based on end user, the market is sub-divided into hospitals, surgical clinics, and research institutions.
Global Tumor Ablation Market Share by Technology, 2021 (%)
Radiofrequency Ablation Segment is projected to Grow at the Fastest Rate During the Forecast Period
The radiofrequency ablation segment is expected to hold a prominent share in the global tumor ablation market. Radiofrequency ablation (RFA) is a minimal invasive procedure, appropriate for treating cardiac diseases such as atrial fibrillation (AF), arterial flutter, cancer, and pain management. The use of ultrasound ablation technology in radiofrequency ablation is also augmenting the popularity of this device. Key players are investing to expand their reach and strengthen their position to stay competitive in the market. For instance, in November 2020, Abbott announced the new launch of the IonicRF Generator, a new device that gets clearance from the FDA to deliver nonsurgical, minimally invasive treatment for the management of pain in the nervous system. The IonicRF generator is a radio frequency ablation devices approved in the US and Europe.
Regional Outlooks
The global tumor ablation market is further segmented based on geography including North America (the US, and Canada Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The Asia Pacific is expected to have the highest CAGR in this market due to the improvement in the healthcare industry and the government support for adopting such technology.
Global Tumor Ablation Market Growth, by Region 2021-2028
North America Region is Proved to be the Largest Region for Global Tumor Ablation Market
North America is holding the largest market share of the global tumor ablation market. The growth is mainly driven by the increasing geriatric population, as the body’s biological functions get compromised with aging, and hence become the main target to get suffered from a tumor. According to the Cancer.gov.org, as of January 1, 2019, an estimated 1,944,280 adults ages 85 and older were alive with a history of cancer, representing one-third of all men and one-fourth of all women in this age group in the US. The oldest old are the fastest-growing group of cancer survivors, with nearly 4.7 million cancer survivors ages 85 and older expected by 2040. Moreover, technological advancements and the presence of major key players in the US and Canada region have fueled the growth of the market.
Market Players Outlook
The major companies serving the global tumor ablation market Boston Scientific Corp., BTG plc, BVM Medical Ltd., Erbe Elektromedizin GmbH, Healthtronics, Inc., Hologic Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2022, Quantum Surgical announced that it has received FDA510 (k) clearance for its Epione interventional oncology robotics platform. The company designed a robot-assisted Epione system to plan, target, deliver and confirm tumor ablation in minimally invasive liver cancer treatment.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global tumor ablation market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Tumor Ablation Market
• Recovery Scenario of Global Tumor Ablation Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
4. Market Segmentation
4.1. Global Tumor Ablation Market by Technology
4.1.1. Radio Frequency Ablation
4.1.2. Microwave Ablation
4.1.3. Cryoablation
4.1.4. Percutaneous Ethanol Ablation
4.2. Global Tumor Ablation Market by Application
4.2.1. Liver Cancer
4.2.2. Lung Cancer
4.2.3. Breast Cancer
4.2.4. Prostate Cancer
4.2.5. Others
4.3. Global Tumor Ablation Market by End-User
4.3.1. Hospitals
4.3.2. Surgical Clinics
4.3.3. Research Institutions
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Afreeze GmbH
6.2. Alpinion Medical Systems
6.3. Atricure
6.4. ATS Medical, Inc.
6.5. Biosig Technologies, Inc.
6.6. Biotronik Se & Co. Kg
6.7. Boston Scientific Corp.
6.8. BTG plc
6.9. BVM Medical Ltd
6.10. Erbe Elektromedizin GmbH
6.11. Healthtronics, Inc.
6.12. Hologic Inc.
6.13. Icecure Medical Ltd
6.14. Integra Lifesciences
6.15. Koninklijke Philips N.V
6.16. Medtronic Plc
6.17. Medwaves Inc.
6.18. Pentax Medical
6.19. Stryker
1. GLOBAL TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028($ MILLION)
2. GLOBAL RADIO FREQUENCY ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
3. GLOBAL MICROWAVE ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
4. GLOBAL CRYOABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
5. GLOBAL PERCUTANEOUS ETHANOL ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
6. GLOBAL TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028($ MILLION)
7. GLOBAL LIVER CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
8. GLOBAL LUNG CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
9. GLOBAL BREAST CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
10. GLOBAL PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
11. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
12. GLOBAL TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028($ MILLION)
13. GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
14. GLOBAL SURGICAL CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
15. GLOBAL RESEARCH INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
16. GLOBAL TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028($ MILLION)
17. NORTH AMERICA TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION
18. NORTH AMERICA TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028($ MILLION)
19. NORTH AMERICA TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028($ MILLION)
20. NORTH AMERICA TUMOR ABLATION MARKET RESEARCH AND ANALYSIS, BY END-USER, 2021-2028($ MILLION)
21. EUROPE TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION)
22. EUROPE TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028($ MILLION)
23. EUROPE TUMOR ABLATION MARKET, MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028($ MILLION)
24. EUROPE TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028($ MILLION)
25. ASIA-PACIFIC TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION)
26. ASIA-PACIFIC TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028($ MILLION)
27. ASIA-PACIFIC TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028($ MILLION)
28. ASIA PACIFIC TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028($ MILLION)
29. REST OF THE WORLD TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
30. REST OF THE WORLD TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
31. REST OF THE WORLD TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL TUMOR ABLATION MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL TUMOR ABLATION MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL TUMOR ABLATION MARKET, 2022-2028 (%)
4. GLOBAL TUMOR ABLATION MARKET SHARE BY TECHNOLOGY, 2021 VS 2028 (%)
5. GLOBAL RADIO FREQUENCY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL MICROWAVE INHIBITORS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL CRYOABLATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL PERCUTANEOUS ETHANOL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL CRYOABLATION INHIBITORS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL TUMOR ABLATION MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
11. GLOBAL LIVER CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL LUNG CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL BREAST CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL PROSTATE CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL TUMOR ABLATION MARKET SHARE BY END-USER, 2021 VS 2028 (%)
17. GLOBAL HOSPITALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. GLOBAL SURGICAL CLINICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
19. GLOBAL RESEARCH INSTITUTIONS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
20. US TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
21. CANADA TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
22. UK TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
23. FRANCE TUMOR ABLATIONMARKET SIZE, 2021-2028 ($ MILLION)
24. GERMANY TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
25. ITALY TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
26. SPAIN TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
27. REST OF EUROPE TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
28. INDIA TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
29. CHINA TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
30. JAPAN TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
31. SOUTH KOREA TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
32. REST OF ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
33. REST OF THE WORLD TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
